# P & L Development LLC, Copiague, NY – FDA Inspections

Source: https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91

> Inspection records and compliance data for P & L Development LLC in Copiague, New York. 9 FDA inspections on record, last inspected May 21, 2025.

---

## Details

- Name: P & L Development LLC
- FEI Number: 2410283
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK
- Address Line 1: 33 Ralph Ave
- City: Copiague
- State: New York
- Zip Code: 11726
- Country Name: United States
- Address: 33 Ralph Ave, Copiague, New York 11726, United States
- Country: United States

## Related Documents

- FDA Inspection 1272786 - P & L Development LLC - 2025-05-21 — source: FDA, date: May 21, 2025
- FDA Inspection 1272786 - P & L Development LLC - 2025-05-21 — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2025
- FDA Inspection 1076220 - P & L Development LLC - 2018-12-13 — source: FDA, date: December 13, 2018
- FDA Inspection 913299 - P & L Development LLC - 2015-02-09 — classification: No Action Indicated (NAI), source: FDA, date: February 9, 2015
- FDA Inspection 864078 - P & L Development LLC - 2014-01-30 — classification: No Action Indicated (NAI), source: FDA, date: January 30, 2014
- FDA Inspection 816949 - P & L Development LLC - 2013-02-01 — classification: No Action Indicated (NAI), source: FDA, date: February 1, 2013
- FDA Inspection 775147 - P & L Development LLC - 2012-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2012
- FDA Inspection 717108 - P & L Development LLC - 2011-03-28 — classification: No Action Indicated (NAI), source: FDA, date: March 28, 2011
- FDA Inspection 639945 - P & L Development LLC - 2010-01-19 — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2010
- [FDA Inspection 556609 - P & L Development LLC - 2009-01-14](https://www.keypedia.com/records/fda_inspections/p-l-development-llc/6df81c34-a8b1-45de-893f-21f012ad88cc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2009

## Related Companies

- [PharmaMax Pharmaceuticals, Ltd.](https://www.keypedia.com/companies/pharmamax-pharmaceuticals-ltd/36995055-289f-4dec-a34c-fe75a137e22b)
- [Avara Pharmaceutical Technologies, Inc.](https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2)
- [Braintree, A part of SEBELA Pharmaceuticals](https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2)
- [DPT Laboratories Ltd.](https://www.keypedia.com/companies/dpt-laboratories-ltd/3b2d6611-9567-4aa0-8e8c-25e1e0a1714e)
- [Mylan Technologies, Inc.](https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70)
- [HIBROW HEALTHCARE PRIVATE LIMITED](https://www.keypedia.com/companies/hibrow-healthcare-private-limited/c5de7b11-f0fd-48a0-9bf9-e7730c9dc8fe)
- [Merck Sharp & Dohme BV](https://www.keypedia.com/companies/merck-sharp-dohme-bv/81aa374d-0950-4e79-a6be-41213e62bbad)
- [Procter & Gamble Manufacturing GmbH](https://www.keypedia.com/companies/procter-gamble-manufacturing-gmbh/cf84472c-85aa-4f88-a965-90093db6d00f)